Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An ARChiVe Registry Cohort Study
Article Swipe
Samuel J Gagne
,
Vidya Sivaraman
,
Else S. Bosman
,
Brett Klamer
,
Kimberly Morishita
,
Adam M. Huber
,
Alvaro Orjuela
,
B. Anne Eberhard
,
Charlotte Myrup
,
Dana Gerstbacher
,
Dirk Foell
,
Eslam Al‐Abadi
,
Flora McErlane
,
Kathryn Cook
,
Linda Wagner‐Weiner
,
Melissa E. Elder
,
L. Nandini Moorthy
,
Paul Dancey
,
Rae S. M. Yeung
,
Raju Khubchandani
,
Samundeeswari Deepak
,
Sirirat Charuvanij
,
Stacey E. Tarvin
,
Susan Shenoi
,
Tamara Tanner
,
Kelly L. Brown
,
David A. Cabral
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1002/acr.25455
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1002/acr.25455
Objective Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are chronic life‐threatening vasculitides requiring substantial immunotherapy. Adult trials identified rituximab (RTX) as an alternative to cyclophosphamide (CYC) for remission induction of GPA and MPA. Disease rarity has limited feasibility of similar trials with pediatric patients. We aim to evaluate the relative efficacy and toxicity of CYC and RTX for patients with childhood GPA and MPA through registry‐based comparative evaluation. Methods From A Registry of Childhood Vasculitis, we identified patients with GPA and MPA who received induction with RTX or CYC. Pediatric Vasculitis Activity Score (PVAS) and Pediatric Vasculitis Damage Index (pVDI) score evaluated disease activity and damage. Descriptive statistics summarized patient characteristics. RTX and CYC comparisons used logistic regression for primary outcomes of postinduction remission (PVAS = 0) or low disease activity (PVAS ≤ 2). Hospital admission for adverse events and pVDI scores were compared using logistic regression and ordinal regression, respectively. Results Among 104 patients, 43% received RTX, 46% CYC, 11% both. Treatment groups did not significantly differ for diagnosis PVAS and onset age. There was no difference in remission among the groups (63% overall; odds ratio [OR] 1.07, 95% confidence interval [CI] 0.45–2.52). Hospitalizations occurred in 22% of patients receiving RTX versus 10% patients receiving CYC (OR 2.27, 95% CI 0.73–7.05). The median 12‐month pVDI score was 1 in both groups (OR 0.98, 95% CI 0.43–2.22). Conclusion This is the first study comparing CYC and RTX for induction in pediatric GPA and MPA. No significant differences were shown in rates of remission, severe adverse events, or organ damage. Limitations included lack of standardized treatment regimens, retrospectivity, and lack of longitudinal adverse drug‐related event data.
Related Topics
Concepts
Medicine
Cyclophosphamide
Rituximab
Internal medicine
Vasculitis
Adverse effect
Granulomatosis with polyangiitis
Logistic regression
Cohort
Microscopic polyangiitis
Gastroenterology
Immunology
Disease
Lymphoma
Chemotherapy
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/acr.25455
- OA Status
- hybrid
- Cited By
- 4
- References
- 32
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4403825907
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4403825907Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/acr.25455Digital Object Identifier
- Title
-
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An
ARChiVe Registry Cohort StudyWork title - Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-10-28Full publication date if available
- Authors
-
Samuel J Gagne, Vidya Sivaraman, Else S. Bosman, Brett Klamer, Kimberly Morishita, Adam M. Huber, Alvaro Orjuela, B. Anne Eberhard, Charlotte Myrup, Dana Gerstbacher, Dirk Foell, Eslam Al‐Abadi, Flora McErlane, Kathryn Cook, Linda Wagner‐Weiner, Melissa E. Elder, L. Nandini Moorthy, Paul Dancey, Rae S. M. Yeung, Raju Khubchandani, Samundeeswari Deepak, Sirirat Charuvanij, Stacey E. Tarvin, Susan Shenoi, Tamara Tanner, Kelly L. Brown, David A. CabralList of authors in order
- Landing page
-
https://doi.org/10.1002/acr.25455Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1002/acr.25455Direct OA link when available
- Concepts
-
Medicine, Cyclophosphamide, Rituximab, Internal medicine, Vasculitis, Adverse effect, Granulomatosis with polyangiitis, Logistic regression, Cohort, Microscopic polyangiitis, Gastroenterology, Immunology, Disease, Lymphoma, ChemotherapyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4Per-year citation counts (last 5 years)
- References (count)
-
32Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4403825907 |
|---|---|
| doi | https://doi.org/10.1002/acr.25455 |
| ids.doi | https://doi.org/10.1002/acr.25455 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39467015 |
| ids.openalex | https://openalex.org/W4403825907 |
| fwci | 3.45049257 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D000069283 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Rituximab |
| mesh[2].qualifier_ui | Q000009 |
| mesh[2].descriptor_ui | D000069283 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | adverse effects |
| mesh[2].descriptor_name | Rituximab |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D012042 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Registries |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D003520 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Cyclophosphamide |
| mesh[5].qualifier_ui | Q000009 |
| mesh[5].descriptor_ui | D003520 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | adverse effects |
| mesh[5].descriptor_name | Cyclophosphamide |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008297 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Male |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D002648 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Child |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000293 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Adolescent |
| mesh[10].qualifier_ui | Q000188 |
| mesh[10].descriptor_ui | D056648 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | drug therapy |
| mesh[10].descriptor_name | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D016896 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Treatment Outcome |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D017668 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Age of Onset |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D012074 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Remission Induction |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D014890 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Granulomatosis with Polyangiitis |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D002675 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Child, Preschool |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D007166 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Immunosuppressive Agents |
| mesh[17].qualifier_ui | Q000009 |
| mesh[17].descriptor_ui | D007166 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | adverse effects |
| mesh[17].descriptor_name | Immunosuppressive Agents |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D015331 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Cohort Studies |
| mesh[19].qualifier_ui | Q000188 |
| mesh[19].descriptor_ui | D055953 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | drug therapy |
| mesh[19].descriptor_name | Microscopic Polyangiitis |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D060828 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Induction Chemotherapy |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D000069283 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Rituximab |
| mesh[23].qualifier_ui | Q000009 |
| mesh[23].descriptor_ui | D000069283 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | adverse effects |
| mesh[23].descriptor_name | Rituximab |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D012042 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Registries |
| mesh[25].qualifier_ui | Q000627 |
| mesh[25].descriptor_ui | D003520 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | therapeutic use |
| mesh[25].descriptor_name | Cyclophosphamide |
| mesh[26].qualifier_ui | Q000009 |
| mesh[26].descriptor_ui | D003520 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | adverse effects |
| mesh[26].descriptor_name | Cyclophosphamide |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008297 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Male |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D005260 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Female |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D002648 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Child |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000293 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Adolescent |
| mesh[31].qualifier_ui | Q000188 |
| mesh[31].descriptor_ui | D056648 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | drug therapy |
| mesh[31].descriptor_name | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D016896 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Treatment Outcome |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D017668 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Age of Onset |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D012074 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Remission Induction |
| mesh[35].qualifier_ui | Q000188 |
| mesh[35].descriptor_ui | D014890 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | drug therapy |
| mesh[35].descriptor_name | Granulomatosis with Polyangiitis |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D002675 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Child, Preschool |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D007166 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Immunosuppressive Agents |
| mesh[38].qualifier_ui | Q000009 |
| mesh[38].descriptor_ui | D007166 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | adverse effects |
| mesh[38].descriptor_name | Immunosuppressive Agents |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D015331 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Cohort Studies |
| mesh[40].qualifier_ui | Q000188 |
| mesh[40].descriptor_ui | D055953 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | drug therapy |
| mesh[40].descriptor_name | Microscopic Polyangiitis |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D060828 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Induction Chemotherapy |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D006801 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Humans |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D000069283 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Rituximab |
| mesh[44].qualifier_ui | Q000009 |
| mesh[44].descriptor_ui | D000069283 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | adverse effects |
| mesh[44].descriptor_name | Rituximab |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D012042 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Registries |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D008297 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Male |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D005260 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Female |
| mesh[48].qualifier_ui | Q000627 |
| mesh[48].descriptor_ui | D003520 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | therapeutic use |
| mesh[48].descriptor_name | Cyclophosphamide |
| mesh[49].qualifier_ui | Q000009 |
| mesh[49].descriptor_ui | D003520 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | adverse effects |
| mesh[49].descriptor_name | Cyclophosphamide |
| type | article |
| title | Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An |
| biblio.issue | 4 |
| biblio.volume | 77 |
| biblio.last_page | 512 |
| biblio.first_page | 504 |
| topics[0].id | https://openalex.org/T10697 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994999766349792 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Vasculitis and related conditions |
| topics[1].id | https://openalex.org/T11029 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9950000047683716 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2727 |
| topics[1].subfield.display_name | Nephrology |
| topics[1].display_name | Renal Diseases and Glomerulopathies |
| topics[2].id | https://openalex.org/T10993 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9835000038146973 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Complement system in diseases |
| is_xpac | False |
| apc_list.value | 4640 |
| apc_list.currency | USD |
| apc_list.value_usd | 4640 |
| apc_paid.value | 4640 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4640 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8757529258728027 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776755627 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7603728771209717 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q408524 |
| concepts[1].display_name | Cyclophosphamide |
| concepts[2].id | https://openalex.org/C2780653079 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7191804647445679 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q412323 |
| concepts[2].display_name | Rituximab |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6304082870483398 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2776015282 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6155052185058594 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q644318 |
| concepts[4].display_name | Vasculitis |
| concepts[5].id | https://openalex.org/C197934379 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5879366397857666 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[5].display_name | Adverse effect |
| concepts[6].id | https://openalex.org/C2781229154 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5842306613922119 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1161568 |
| concepts[6].display_name | Granulomatosis with polyangiitis |
| concepts[7].id | https://openalex.org/C151956035 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5563240051269531 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1132755 |
| concepts[7].display_name | Logistic regression |
| concepts[8].id | https://openalex.org/C72563966 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4863587021827698 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[8].display_name | Cohort |
| concepts[9].id | https://openalex.org/C2778910314 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4837896525859833 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1934069 |
| concepts[9].display_name | Microscopic polyangiitis |
| concepts[10].id | https://openalex.org/C90924648 |
| concepts[10].level | 1 |
| concepts[10].score | 0.35311204195022583 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[10].display_name | Gastroenterology |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.32270875573158264 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C2779134260 |
| concepts[12].level | 2 |
| concepts[12].score | 0.31350088119506836 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[12].display_name | Disease |
| concepts[13].id | https://openalex.org/C2779338263 |
| concepts[13].level | 2 |
| concepts[13].score | 0.15669137239456177 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[13].display_name | Lymphoma |
| concepts[14].id | https://openalex.org/C2776694085 |
| concepts[14].level | 2 |
| concepts[14].score | 0.14082130789756775 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[14].display_name | Chemotherapy |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8757529258728027 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/cyclophosphamide |
| keywords[1].score | 0.7603728771209717 |
| keywords[1].display_name | Cyclophosphamide |
| keywords[2].id | https://openalex.org/keywords/rituximab |
| keywords[2].score | 0.7191804647445679 |
| keywords[2].display_name | Rituximab |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6304082870483398 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/vasculitis |
| keywords[4].score | 0.6155052185058594 |
| keywords[4].display_name | Vasculitis |
| keywords[5].id | https://openalex.org/keywords/adverse-effect |
| keywords[5].score | 0.5879366397857666 |
| keywords[5].display_name | Adverse effect |
| keywords[6].id | https://openalex.org/keywords/granulomatosis-with-polyangiitis |
| keywords[6].score | 0.5842306613922119 |
| keywords[6].display_name | Granulomatosis with polyangiitis |
| keywords[7].id | https://openalex.org/keywords/logistic-regression |
| keywords[7].score | 0.5563240051269531 |
| keywords[7].display_name | Logistic regression |
| keywords[8].id | https://openalex.org/keywords/cohort |
| keywords[8].score | 0.4863587021827698 |
| keywords[8].display_name | Cohort |
| keywords[9].id | https://openalex.org/keywords/microscopic-polyangiitis |
| keywords[9].score | 0.4837896525859833 |
| keywords[9].display_name | Microscopic polyangiitis |
| keywords[10].id | https://openalex.org/keywords/gastroenterology |
| keywords[10].score | 0.35311204195022583 |
| keywords[10].display_name | Gastroenterology |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.32270875573158264 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/disease |
| keywords[12].score | 0.31350088119506836 |
| keywords[12].display_name | Disease |
| keywords[13].id | https://openalex.org/keywords/lymphoma |
| keywords[13].score | 0.15669137239456177 |
| keywords[13].display_name | Lymphoma |
| keywords[14].id | https://openalex.org/keywords/chemotherapy |
| keywords[14].score | 0.14082130789756775 |
| keywords[14].display_name | Chemotherapy |
| language | en |
| locations[0].id | doi:10.1002/acr.25455 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S13698240 |
| locations[0].source.issn | 2151-464X, 2151-4658 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2151-464X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Arthritis Care & Research |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Arthritis Care & Research |
| locations[0].landing_page_url | https://doi.org/10.1002/acr.25455 |
| locations[1].id | pmid:39467015 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Arthritis care & research |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39467015 |
| locations[2].id | pmh:oai:europepmc.org:10743546 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11931354 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5109629399 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3432-296X |
| authorships[0].author.display_name | Samuel J Gagne |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210130600 |
| authorships[0].affiliations[0].raw_affiliation_string | Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I170201317 |
| authorships[0].affiliations[1].raw_affiliation_string | University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[0].institutions[0].id | https://openalex.org/I4210130600 |
| authorships[0].institutions[0].ror | https://ror.org/03763ep67 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210098814, https://openalex.org/I4210130600, https://openalex.org/I4210134769 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Children's Hospital of Pittsburgh |
| authorships[0].institutions[1].id | https://openalex.org/I170201317 |
| authorships[0].institutions[1].ror | https://ror.org/01an3r305 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I170201317 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | University of Pittsburgh |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Samuel J Gagne |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, University of Pittsburgh School of Medicine, Pittsburgh, PA |
| authorships[1].author.id | https://openalex.org/A5021973400 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3077-6726 |
| authorships[1].author.display_name | Vidya Sivaraman |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1314135232 |
| authorships[1].affiliations[0].raw_affiliation_string | Nationwide Children's Hospital, Rheumatology, Columbus, OH |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I52357470 |
| authorships[1].affiliations[1].raw_affiliation_string | The Ohio State University, Columbus, OH |
| authorships[1].institutions[0].id | https://openalex.org/I1314135232 |
| authorships[1].institutions[0].ror | https://ror.org/003rfsp33 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1314135232 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Nationwide Children's Hospital |
| authorships[1].institutions[1].id | https://openalex.org/I52357470 |
| authorships[1].institutions[1].ror | https://ror.org/00rs6vg23 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I52357470 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | The Ohio State University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Vidya Sivaraman |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Nationwide Children's Hospital, Rheumatology, Columbus, OH, The Ohio State University, Columbus, OH |
| authorships[2].author.id | https://openalex.org/A5015281083 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6575-2084 |
| authorships[2].author.display_name | Else S. Bosman |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210153200 |
| authorships[2].affiliations[0].raw_affiliation_string | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[2].institutions[0].id | https://openalex.org/I4210153200 |
| authorships[2].institutions[0].ror | https://ror.org/04n901w50 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210153200 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | BC Children's Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Else S. Bosman |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[3].author.id | https://openalex.org/A5032172599 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8334-4831 |
| authorships[3].author.display_name | Brett Klamer |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I52357470 |
| authorships[3].affiliations[0].raw_affiliation_string | The Ohio State University School of Biomedical Science, Center for Biostatistics Columbus, OH |
| authorships[3].institutions[0].id | https://openalex.org/I52357470 |
| authorships[3].institutions[0].ror | https://ror.org/00rs6vg23 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I52357470 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | The Ohio State University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Brett Klamer |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | The Ohio State University School of Biomedical Science, Center for Biostatistics Columbus, OH |
| authorships[4].author.id | https://openalex.org/A5064061297 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1389-4002 |
| authorships[4].author.display_name | Kimberly Morishita |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210153200 |
| authorships[4].affiliations[0].raw_affiliation_string | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[4].institutions[0].id | https://openalex.org/I4210153200 |
| authorships[4].institutions[0].ror | https://ror.org/04n901w50 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210153200 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | BC Children's Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kimberly A. Morishita |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[5].author.id | https://openalex.org/A5015352382 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6616-1689 |
| authorships[5].author.display_name | Adam M. Huber |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I129902397, https://openalex.org/I2800394539 |
| authorships[5].affiliations[0].raw_affiliation_string | IWK Health Centre/Dalhousie University, Halifax, NS |
| authorships[5].institutions[0].id | https://openalex.org/I129902397 |
| authorships[5].institutions[0].ror | https://ror.org/01e6qks80 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I129902397 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Dalhousie University |
| authorships[5].institutions[1].id | https://openalex.org/I2800394539 |
| authorships[5].institutions[1].ror | https://ror.org/0064zg438 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I2800394539 |
| authorships[5].institutions[1].country_code | CA |
| authorships[5].institutions[1].display_name | Izaak Walton Killam Health Centre |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Adam Huber |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | IWK Health Centre/Dalhousie University, Halifax, NS |
| authorships[6].author.id | https://openalex.org/A5040792059 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Alvaro Orjuela |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210147586 |
| authorships[6].affiliations[0].raw_affiliation_string | Texas Children's Hospital, Houston, TX |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I181547552 |
| authorships[6].affiliations[1].raw_affiliation_string | Baylor College of Medicine, Houston, TX |
| authorships[6].institutions[0].id | https://openalex.org/I181547552 |
| authorships[6].institutions[0].ror | https://ror.org/02pttbw34 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I181547552, https://openalex.org/I2801539370 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Baylor College of Medicine |
| authorships[6].institutions[1].id | https://openalex.org/I4210147586 |
| authorships[6].institutions[1].ror | https://ror.org/05cz92x43 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210147586 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | Texas Children's Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Alvaro Orjuela |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Baylor College of Medicine, Houston, TX, Texas Children's Hospital, Houston, TX |
| authorships[7].author.id | https://openalex.org/A5090678049 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | B. Anne Eberhard |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1302444339, https://openalex.org/I4210116459 |
| authorships[7].affiliations[0].raw_affiliation_string | Cohen Children's Northwell Health, New Hyde Park, NY |
| authorships[7].institutions[0].id | https://openalex.org/I4210116459 |
| authorships[7].institutions[0].ror | https://ror.org/026n33e29 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I1302444339, https://openalex.org/I2800560132, https://openalex.org/I4210116459 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Cohen Children's Medical Center |
| authorships[7].institutions[1].id | https://openalex.org/I1302444339 |
| authorships[7].institutions[1].ror | https://ror.org/02bxt4m23 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I1302444339 |
| authorships[7].institutions[1].country_code | US |
| authorships[7].institutions[1].display_name | Northwell Health |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Barbara Eberhard |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Cohen Children's Northwell Health, New Hyde Park, NY |
| authorships[8].author.id | https://openalex.org/A5060454791 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6960-7466 |
| authorships[8].author.display_name | Charlotte Myrup |
| authorships[8].countries | DK |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2802567020 |
| authorships[8].affiliations[0].raw_affiliation_string | Copenhagen University Hospital, Copenhagen, DK |
| authorships[8].institutions[0].id | https://openalex.org/I2802567020 |
| authorships[8].institutions[0].ror | https://ror.org/05bpbnx46 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2802567020 |
| authorships[8].institutions[0].country_code | DK |
| authorships[8].institutions[0].display_name | Copenhagen University Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Charlotte Myrup |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Copenhagen University Hospital, Copenhagen, DK |
| authorships[9].author.id | https://openalex.org/A5054460357 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-7135-6766 |
| authorships[9].author.display_name | Dana Gerstbacher |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1334016132 |
| authorships[9].affiliations[0].raw_affiliation_string | Stanford Children's Hospital, Palo Alto, CA |
| authorships[9].institutions[0].id | https://openalex.org/I1334016132 |
| authorships[9].institutions[0].ror | https://ror.org/05a25vm86 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1334016132, https://openalex.org/I4210137306, https://openalex.org/I97018004 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Lucile Packard Children's Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Dana Gerstbacher |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Stanford Children's Hospital, Palo Alto, CA |
| authorships[10].author.id | https://openalex.org/A5040230445 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-1946-3916 |
| authorships[10].author.display_name | Dirk Foell |
| authorships[10].countries | DE |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I22465464 |
| authorships[10].affiliations[0].raw_affiliation_string | University of Muenster, Muenster, Germany |
| authorships[10].institutions[0].id | https://openalex.org/I22465464 |
| authorships[10].institutions[0].ror | https://ror.org/00pd74e08 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I22465464 |
| authorships[10].institutions[0].country_code | DE |
| authorships[10].institutions[0].display_name | University of Münster |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Dirk Foell |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | University of Muenster, Muenster, Germany |
| authorships[11].author.id | https://openalex.org/A5091100617 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-1999-6341 |
| authorships[11].author.display_name | Eslam Al‐Abadi |
| authorships[11].countries | GB |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210100347 |
| authorships[11].affiliations[0].raw_affiliation_string | Birmingham Children's Hospital, Birmingham, UK |
| authorships[11].institutions[0].id | https://openalex.org/I4210100347 |
| authorships[11].institutions[0].ror | https://ror.org/017k80q27 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210100347, https://openalex.org/I4210155225 |
| authorships[11].institutions[0].country_code | GB |
| authorships[11].institutions[0].display_name | Birmingham Children's Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Eslam Al‐Abadi |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Birmingham Children's Hospital, Birmingham, UK |
| authorships[12].author.id | https://openalex.org/A5090311068 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-2328-2122 |
| authorships[12].author.display_name | Flora McErlane |
| authorships[12].countries | GB |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210138797 |
| authorships[12].affiliations[0].raw_affiliation_string | Great North Children's Hospital, Newcastle Upon Tyne, UK |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I84884186 |
| authorships[12].affiliations[1].raw_affiliation_string | Newcastle University Population Health Sciences Institute, Newcastle upon Tyne, UK |
| authorships[12].institutions[0].id | https://openalex.org/I4210138797 |
| authorships[12].institutions[0].ror | https://ror.org/0483p1w82 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I2801663869, https://openalex.org/I4210138797 |
| authorships[12].institutions[0].country_code | GB |
| authorships[12].institutions[0].display_name | Great North Children's Hospital |
| authorships[12].institutions[1].id | https://openalex.org/I84884186 |
| authorships[12].institutions[1].ror | https://ror.org/01kj2bm70 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I84884186 |
| authorships[12].institutions[1].country_code | GB |
| authorships[12].institutions[1].display_name | Newcastle University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Flora McErlane |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Great North Children's Hospital, Newcastle Upon Tyne, UK, Newcastle University Population Health Sciences Institute, Newcastle upon Tyne, UK |
| authorships[13].author.id | https://openalex.org/A5089568587 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-4490-9377 |
| authorships[13].author.display_name | Kathryn Cook |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210098750 |
| authorships[13].affiliations[0].raw_affiliation_string | Akron Children's Hospital, Akron, OH |
| authorships[13].institutions[0].id | https://openalex.org/I4210098750 |
| authorships[13].institutions[0].ror | https://ror.org/0107t3e14 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210098750 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Akron Children's Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Kathryn Cook |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Akron Children's Hospital, Akron, OH |
| authorships[14].author.id | https://openalex.org/A5057881013 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-0932-2981 |
| authorships[14].author.display_name | Linda Wagner‐Weiner |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210087865 |
| authorships[14].affiliations[0].raw_affiliation_string | The University of Chicago Medical Center, Chicago, IL |
| authorships[14].institutions[0].id | https://openalex.org/I4210087865 |
| authorships[14].institutions[0].ror | https://ror.org/0076kfe04 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210087865 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | University of Chicago Medical Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Linda Wagner‐Weiner |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | The University of Chicago Medical Center, Chicago, IL |
| authorships[15].author.id | https://openalex.org/A5026703022 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-8820-5515 |
| authorships[15].author.display_name | Melissa E. Elder |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I33213144 |
| authorships[15].affiliations[0].raw_affiliation_string | University of Florida, Gainesville, FL |
| authorships[15].institutions[0].id | https://openalex.org/I33213144 |
| authorships[15].institutions[0].ror | https://ror.org/02y3ad647 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I33213144 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | University of Florida |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Melissa Elder |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | University of Florida, Gainesville, FL |
| authorships[16].author.id | https://openalex.org/A5074916296 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-9410-2099 |
| authorships[16].author.display_name | L. Nandini Moorthy |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I2802203029 |
| authorships[16].affiliations[0].raw_affiliation_string | Robert Wood Johnson Medical School, New Brunswick, NJ |
| authorships[16].institutions[0].id | https://openalex.org/I2802203029 |
| authorships[16].institutions[0].ror | https://ror.org/04dpnfr42 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I2802203029 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Johnson University |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | L. Nandini Moorthy |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Robert Wood Johnson Medical School, New Brunswick, NJ |
| authorships[17].author.id | https://openalex.org/A5004228996 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-5998-9608 |
| authorships[17].author.display_name | Paul Dancey |
| authorships[17].countries | CA, US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I2801471284, https://openalex.org/I4210140353 |
| authorships[17].affiliations[0].raw_affiliation_string | Janeway Children's Health and Rehabilitation Centre, St. John's, NL |
| authorships[17].institutions[0].id | https://openalex.org/I2801471284 |
| authorships[17].institutions[0].ror | https://ror.org/05j96kg65 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I2801471284 |
| authorships[17].institutions[0].country_code | CA |
| authorships[17].institutions[0].display_name | Janeway Children's Health and Rehabilitation Centre |
| authorships[17].institutions[1].id | https://openalex.org/I4210140353 |
| authorships[17].institutions[1].ror | https://ror.org/03e4a0h58 |
| authorships[17].institutions[1].type | education |
| authorships[17].institutions[1].lineage | https://openalex.org/I4210140353 |
| authorships[17].institutions[1].country_code | US |
| authorships[17].institutions[1].display_name | St. John's School |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Paul Dancey |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Janeway Children's Health and Rehabilitation Centre, St. John's, NL |
| authorships[18].author.id | https://openalex.org/A5040872283 |
| authorships[18].author.orcid | https://orcid.org/0000-0003-2361-725X |
| authorships[18].author.display_name | Rae S. M. Yeung |
| authorships[18].countries | CA |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I185261750, https://openalex.org/I2801317318 |
| authorships[18].affiliations[0].raw_affiliation_string | The Hospital for Sick Children and University of Toronto, Toronto, ON |
| authorships[18].institutions[0].id | https://openalex.org/I2801317318 |
| authorships[18].institutions[0].ror | https://ror.org/057q4rt57 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I2801317318 |
| authorships[18].institutions[0].country_code | CA |
| authorships[18].institutions[0].display_name | Hospital for Sick Children |
| authorships[18].institutions[1].id | https://openalex.org/I185261750 |
| authorships[18].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[18].institutions[1].type | education |
| authorships[18].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[18].institutions[1].country_code | CA |
| authorships[18].institutions[1].display_name | University of Toronto |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Rae Yeung |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | The Hospital for Sick Children and University of Toronto, Toronto, ON |
| authorships[19].author.id | https://openalex.org/A5045740982 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-0294-119X |
| authorships[19].author.display_name | Raju Khubchandani |
| authorships[19].countries | IN |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210157253 |
| authorships[19].affiliations[0].raw_affiliation_string | SRCC Childrens Hospital, Mumbai, Mumbai, IN |
| authorships[19].institutions[0].id | https://openalex.org/I4210157253 |
| authorships[19].institutions[0].ror | https://ror.org/05hg1ny67 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I288496929, https://openalex.org/I4210157253 |
| authorships[19].institutions[0].country_code | IN |
| authorships[19].institutions[0].display_name | SRCC Children’s Hospital |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Raju Khubchandani |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | SRCC Childrens Hospital, Mumbai, Mumbai, IN |
| authorships[20].author.id | https://openalex.org/A5053827033 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-3222-1441 |
| authorships[20].author.display_name | Samundeeswari Deepak |
| authorships[20].affiliations[0].raw_affiliation_string | Nottingham Children's Hospital, Nottingham, UK |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Samundeeswari Deepak |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Nottingham Children's Hospital, Nottingham, UK |
| authorships[21].author.id | https://openalex.org/A5082773173 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-0506-6039 |
| authorships[21].author.display_name | Sirirat Charuvanij |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I1283055418, https://openalex.org/I2802740592, https://openalex.org/I55769427 |
| authorships[21].affiliations[0].raw_affiliation_string | Riley Hospital for Children at Indiana University Health, Indianapolis, IN |
| authorships[21].institutions[0].id | https://openalex.org/I1283055418 |
| authorships[21].institutions[0].ror | https://ror.org/01aaptx40 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I1283055418, https://openalex.org/I4388446366, https://openalex.org/I592451 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | Indiana University Health |
| authorships[21].institutions[1].id | https://openalex.org/I55769427 |
| authorships[21].institutions[1].ror | https://ror.org/05gxnyn08 |
| authorships[21].institutions[1].type | education |
| authorships[21].institutions[1].lineage | https://openalex.org/I55769427, https://openalex.org/I592451 |
| authorships[21].institutions[1].country_code | US |
| authorships[21].institutions[1].display_name | Indiana University – Purdue University Indianapolis |
| authorships[21].institutions[2].id | https://openalex.org/I2802740592 |
| authorships[21].institutions[2].ror | https://ror.org/03vzvbw58 |
| authorships[21].institutions[2].type | healthcare |
| authorships[21].institutions[2].lineage | https://openalex.org/I1283055418, https://openalex.org/I2802740592, https://openalex.org/I4388446366, https://openalex.org/I4388446366, https://openalex.org/I592451, https://openalex.org/I592451 |
| authorships[21].institutions[2].country_code | US |
| authorships[21].institutions[2].display_name | Riley Hospital for Children |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Sirirat Charuvanij |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Riley Hospital for Children at Indiana University Health, Indianapolis, IN |
| authorships[22].author.id | https://openalex.org/A5091884614 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-8583-7878 |
| authorships[22].author.display_name | Stacey E. Tarvin |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I1295499534 |
| authorships[22].affiliations[0].raw_affiliation_string | Seattle Childrens Hospital, Seattle, WA |
| authorships[22].institutions[0].id | https://openalex.org/I1295499534 |
| authorships[22].institutions[0].ror | https://ror.org/01njes783 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I1295499534 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Seattle Children's Hospital |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Stacey Tarvin |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Seattle Childrens Hospital, Seattle, WA |
| authorships[23].author.id | https://openalex.org/A5035430191 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-2495-594X |
| authorships[23].author.display_name | Susan Shenoi |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I1335289525 |
| authorships[23].affiliations[0].raw_affiliation_string | Montefiore Hospital and Medical Center, Bronx, NY |
| authorships[23].institutions[0].id | https://openalex.org/I1335289525 |
| authorships[23].institutions[0].ror | https://ror.org/044ntvm43 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I1335289525 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | Montefiore Medical Center |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Susan Shenoi |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Montefiore Hospital and Medical Center, Bronx, NY |
| authorships[24].author.id | https://openalex.org/A5111686798 |
| authorships[24].author.orcid | |
| authorships[24].author.display_name | Tamara Tanner |
| authorships[24].countries | TH |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I1332387789, https://openalex.org/I25399158 |
| authorships[24].affiliations[0].raw_affiliation_string | Siriraj Hospital, Mahidol University, Bangkok, TH |
| authorships[24].institutions[0].id | https://openalex.org/I25399158 |
| authorships[24].institutions[0].ror | https://ror.org/01znkr924 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I25399158 |
| authorships[24].institutions[0].country_code | TH |
| authorships[24].institutions[0].display_name | Mahidol University |
| authorships[24].institutions[1].id | https://openalex.org/I1332387789 |
| authorships[24].institutions[1].ror | https://ror.org/0331zs648 |
| authorships[24].institutions[1].type | healthcare |
| authorships[24].institutions[1].lineage | https://openalex.org/I1332387789 |
| authorships[24].institutions[1].country_code | TH |
| authorships[24].institutions[1].display_name | Siriraj Hospital |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Tamara Tanner |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Siriraj Hospital, Mahidol University, Bangkok, TH |
| authorships[25].author.id | https://openalex.org/A5009403492 |
| authorships[25].author.orcid | https://orcid.org/0000-0001-5385-3582 |
| authorships[25].author.display_name | Kelly L. Brown |
| authorships[25].countries | CA |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210153200 |
| authorships[25].affiliations[0].raw_affiliation_string | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[25].institutions[0].id | https://openalex.org/I4210153200 |
| authorships[25].institutions[0].ror | https://ror.org/04n901w50 |
| authorships[25].institutions[0].type | healthcare |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210153200 |
| authorships[25].institutions[0].country_code | CA |
| authorships[25].institutions[0].display_name | BC Children's Hospital |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Kelly Brown |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[26].author.id | https://openalex.org/A5014884266 |
| authorships[26].author.orcid | https://orcid.org/0000-0003-1840-9210 |
| authorships[26].author.display_name | David A. Cabral |
| authorships[26].countries | CA |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I4210153200 |
| authorships[26].affiliations[0].raw_affiliation_string | British Columbia's Children's Hospital, Vancouver, BC |
| authorships[26].institutions[0].id | https://openalex.org/I4210153200 |
| authorships[26].institutions[0].ror | https://ror.org/04n901w50 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I4210153200 |
| authorships[26].institutions[0].country_code | CA |
| authorships[26].institutions[0].display_name | BC Children's Hospital |
| authorships[26].author_position | last |
| authorships[26].raw_author_name | David A. Cabral |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | British Columbia's Children's Hospital, Vancouver, BC |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1002/acr.25455 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2024-10-29T00:00:00 |
| display_name | Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10697 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994999766349792 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Vasculitis and related conditions |
| related_works | https://openalex.org/W4236083053, https://openalex.org/W2019981736, https://openalex.org/W3025812947, https://openalex.org/W3032075507, https://openalex.org/W2258178867, https://openalex.org/W2986935334, https://openalex.org/W4232151264, https://openalex.org/W2578237584, https://openalex.org/W3081393921, https://openalex.org/W2985308153 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/acr.25455 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S13698240 |
| best_oa_location.source.issn | 2151-464X, 2151-4658 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2151-464X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Arthritis Care & Research |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Arthritis Care & Research |
| best_oa_location.landing_page_url | https://doi.org/10.1002/acr.25455 |
| primary_location.id | doi:10.1002/acr.25455 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S13698240 |
| primary_location.source.issn | 2151-464X, 2151-4658 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2151-464X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Arthritis Care & Research |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Arthritis Care & Research |
| primary_location.landing_page_url | https://doi.org/10.1002/acr.25455 |
| publication_date | 2024-10-28 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2000378313, https://openalex.org/W2908342189, https://openalex.org/W2126960177, https://openalex.org/W4206344444, https://openalex.org/W2103283545, https://openalex.org/W2077982979, https://openalex.org/W2163003110, https://openalex.org/W2084056567, https://openalex.org/W1967599448, https://openalex.org/W2921264466, https://openalex.org/W3176922148, https://openalex.org/W2597567673, https://openalex.org/W2768670218, https://openalex.org/W2155005915, https://openalex.org/W2145583696, https://openalex.org/W3028258927, https://openalex.org/W2024564671, https://openalex.org/W4281385325, https://openalex.org/W2063340779, https://openalex.org/W2266467924, https://openalex.org/W3128192703, https://openalex.org/W3181405838, https://openalex.org/W2904419734, https://openalex.org/W3134169580, https://openalex.org/W4226030946, https://openalex.org/W3011426762, https://openalex.org/W2528511825, https://openalex.org/W2007573146, https://openalex.org/W1940843541, https://openalex.org/W2937910100, https://openalex.org/W2970175704, https://openalex.org/W2076736046 |
| referenced_works_count | 32 |
| abstract_inverted_index.1 | 219 |
| abstract_inverted_index.= | 126 |
| abstract_inverted_index.A | 71 |
| abstract_inverted_index.0) | 127 |
| abstract_inverted_index.CI | 211, 226 |
| abstract_inverted_index.No | 245 |
| abstract_inverted_index.We | 45 |
| abstract_inverted_index.an | 22 |
| abstract_inverted_index.as | 21 |
| abstract_inverted_index.in | 179, 197, 220, 240, 250 |
| abstract_inverted_index.is | 230 |
| abstract_inverted_index.no | 177 |
| abstract_inverted_index.of | 30, 39, 54, 73, 122, 199, 252, 263, 270 |
| abstract_inverted_index.or | 88, 128, 257 |
| abstract_inverted_index.to | 24, 47 |
| abstract_inverted_index.we | 76 |
| abstract_inverted_index.(OR | 208, 223 |
| abstract_inverted_index.10% | 204 |
| abstract_inverted_index.104 | 154 |
| abstract_inverted_index.11% | 161 |
| abstract_inverted_index.2). | 134 |
| abstract_inverted_index.22% | 198 |
| abstract_inverted_index.43% | 156 |
| abstract_inverted_index.46% | 159 |
| abstract_inverted_index.95% | 190, 210, 225 |
| abstract_inverted_index.CYC | 55, 114, 207, 235 |
| abstract_inverted_index.GPA | 31, 62, 80, 242 |
| abstract_inverted_index.MPA | 64, 82 |
| abstract_inverted_index.RTX | 57, 87, 112, 202, 237 |
| abstract_inverted_index.The | 213 |
| abstract_inverted_index.aim | 46 |
| abstract_inverted_index.and | 5, 32, 52, 56, 63, 81, 95, 105, 113, 140, 148, 172, 236, 243, 268 |
| abstract_inverted_index.are | 9 |
| abstract_inverted_index.did | 165 |
| abstract_inverted_index.for | 27, 58, 119, 137, 169, 238 |
| abstract_inverted_index.has | 36 |
| abstract_inverted_index.low | 129 |
| abstract_inverted_index.not | 166 |
| abstract_inverted_index.the | 49, 182, 231 |
| abstract_inverted_index.was | 176, 218 |
| abstract_inverted_index.who | 83 |
| abstract_inverted_index.≤ | 133 |
| abstract_inverted_index.(63% | 184 |
| abstract_inverted_index.CYC, | 160 |
| abstract_inverted_index.CYC. | 89 |
| abstract_inverted_index.From | 70 |
| abstract_inverted_index.MPA. | 33, 244 |
| abstract_inverted_index.PVAS | 171 |
| abstract_inverted_index.RTX, | 158 |
| abstract_inverted_index.This | 229 |
| abstract_inverted_index.[CI] | 193 |
| abstract_inverted_index.[OR] | 188 |
| abstract_inverted_index.age. | 174 |
| abstract_inverted_index.both | 221 |
| abstract_inverted_index.lack | 262, 269 |
| abstract_inverted_index.odds | 186 |
| abstract_inverted_index.pVDI | 141, 216 |
| abstract_inverted_index.used | 116 |
| abstract_inverted_index.were | 143, 248 |
| abstract_inverted_index.with | 2, 42, 60, 79, 86 |
| abstract_inverted_index.(CYC) | 26 |
| abstract_inverted_index.(GPA) | 4 |
| abstract_inverted_index.(MPA) | 8 |
| abstract_inverted_index.(PVAS | 125, 132 |
| abstract_inverted_index.(RTX) | 20 |
| abstract_inverted_index.0.98, | 224 |
| abstract_inverted_index.1.07, | 189 |
| abstract_inverted_index.2.27, | 209 |
| abstract_inverted_index.Adult | 16 |
| abstract_inverted_index.Among | 153 |
| abstract_inverted_index.Index | 99 |
| abstract_inverted_index.Score | 93 |
| abstract_inverted_index.There | 175 |
| abstract_inverted_index.among | 181 |
| abstract_inverted_index.both. | 162 |
| abstract_inverted_index.data. | 275 |
| abstract_inverted_index.event | 274 |
| abstract_inverted_index.first | 232 |
| abstract_inverted_index.onset | 173 |
| abstract_inverted_index.organ | 258 |
| abstract_inverted_index.rates | 251 |
| abstract_inverted_index.ratio | 187 |
| abstract_inverted_index.score | 101, 217 |
| abstract_inverted_index.shown | 249 |
| abstract_inverted_index.study | 233 |
| abstract_inverted_index.using | 145 |
| abstract_inverted_index.(PVAS) | 94 |
| abstract_inverted_index.(pVDI) | 100 |
| abstract_inverted_index.Damage | 98 |
| abstract_inverted_index.differ | 168 |
| abstract_inverted_index.events | 139 |
| abstract_inverted_index.groups | 164, 183, 222 |
| abstract_inverted_index.median | 214 |
| abstract_inverted_index.rarity | 35 |
| abstract_inverted_index.scores | 142 |
| abstract_inverted_index.severe | 254 |
| abstract_inverted_index.trials | 17, 41 |
| abstract_inverted_index.versus | 203 |
| abstract_inverted_index.Disease | 34 |
| abstract_inverted_index.Methods | 69 |
| abstract_inverted_index.Results | 152 |
| abstract_inverted_index.adverse | 138, 255, 272 |
| abstract_inverted_index.chronic | 10 |
| abstract_inverted_index.damage. | 106, 259 |
| abstract_inverted_index.disease | 103, 130 |
| abstract_inverted_index.events, | 256 |
| abstract_inverted_index.limited | 37 |
| abstract_inverted_index.ordinal | 149 |
| abstract_inverted_index.patient | 110 |
| abstract_inverted_index.primary | 120 |
| abstract_inverted_index.similar | 40 |
| abstract_inverted_index.through | 65 |
| abstract_inverted_index.Activity | 92 |
| abstract_inverted_index.Hospital | 135 |
| abstract_inverted_index.Registry | 72 |
| abstract_inverted_index.activity | 104, 131 |
| abstract_inverted_index.compared | 144 |
| abstract_inverted_index.efficacy | 51 |
| abstract_inverted_index.evaluate | 48 |
| abstract_inverted_index.included | 261 |
| abstract_inverted_index.interval | 192 |
| abstract_inverted_index.logistic | 117, 146 |
| abstract_inverted_index.occurred | 196 |
| abstract_inverted_index.outcomes | 121 |
| abstract_inverted_index.overall; | 185 |
| abstract_inverted_index.patients | 59, 78, 200, 205 |
| abstract_inverted_index.received | 84, 157 |
| abstract_inverted_index.relative | 50 |
| abstract_inverted_index.toxicity | 53 |
| abstract_inverted_index.Childhood | 74 |
| abstract_inverted_index.Objective | 0 |
| abstract_inverted_index.Pediatric | 90, 96 |
| abstract_inverted_index.Treatment | 163 |
| abstract_inverted_index.admission | 136 |
| abstract_inverted_index.childhood | 61 |
| abstract_inverted_index.comparing | 234 |
| abstract_inverted_index.diagnosis | 170 |
| abstract_inverted_index.evaluated | 102 |
| abstract_inverted_index.induction | 29, 85, 239 |
| abstract_inverted_index.patients, | 155 |
| abstract_inverted_index.patients. | 44 |
| abstract_inverted_index.pediatric | 43, 241 |
| abstract_inverted_index.receiving | 201, 206 |
| abstract_inverted_index.regimens, | 266 |
| abstract_inverted_index.remission | 28, 124, 180 |
| abstract_inverted_index.requiring | 13 |
| abstract_inverted_index.rituximab | 19 |
| abstract_inverted_index.treatment | 265 |
| abstract_inverted_index.12‐month | 215 |
| abstract_inverted_index.Conclusion | 228 |
| abstract_inverted_index.Vasculitis | 91, 97 |
| abstract_inverted_index.confidence | 191 |
| abstract_inverted_index.difference | 178 |
| abstract_inverted_index.identified | 18, 77 |
| abstract_inverted_index.regression | 118, 147 |
| abstract_inverted_index.remission, | 253 |
| abstract_inverted_index.statistics | 108 |
| abstract_inverted_index.summarized | 109 |
| abstract_inverted_index.Descriptive | 107 |
| abstract_inverted_index.Limitations | 260 |
| abstract_inverted_index.Vasculitis, | 75 |
| abstract_inverted_index.alternative | 23 |
| abstract_inverted_index.comparative | 67 |
| abstract_inverted_index.comparisons | 115 |
| abstract_inverted_index.differences | 247 |
| abstract_inverted_index.evaluation. | 68 |
| abstract_inverted_index.feasibility | 38 |
| abstract_inverted_index.microscopic | 6 |
| abstract_inverted_index.regression, | 150 |
| abstract_inverted_index.significant | 246 |
| abstract_inverted_index.substantial | 14 |
| abstract_inverted_index.longitudinal | 271 |
| abstract_inverted_index.polyangiitis | 3, 7 |
| abstract_inverted_index.standardized | 264 |
| abstract_inverted_index.vasculitides | 12 |
| abstract_inverted_index.0.43–2.22). | 227 |
| abstract_inverted_index.0.45–2.52). | 194 |
| abstract_inverted_index.0.73–7.05). | 212 |
| abstract_inverted_index.postinduction | 123 |
| abstract_inverted_index.respectively. | 151 |
| abstract_inverted_index.significantly | 167 |
| abstract_inverted_index.Granulomatosis | 1 |
| abstract_inverted_index.drug‐related | 273 |
| abstract_inverted_index.immunotherapy. | 15 |
| abstract_inverted_index.Hospitalizations | 195 |
| abstract_inverted_index.characteristics. | 111 |
| abstract_inverted_index.cyclophosphamide | 25 |
| abstract_inverted_index.registry‐based | 66 |
| abstract_inverted_index.retrospectivity, | 267 |
| abstract_inverted_index.life‐threatening | 11 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5109629399 |
| countries_distinct_count | 7 |
| institutions_distinct_count | 27 |
| corresponding_institution_ids | https://openalex.org/I170201317, https://openalex.org/I4210130600 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7599999904632568 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.89101176 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |